Cannformatics Announces Publication of Groundbreaking Study Identifying Cannabis-Responsive™ Biomarkers in Children with Autism Spectrum Disorder

SAN FRANCISCO: SAN FRANCISCO, Dec. 8, 2021 /PRNewswire/ -- Study results indicate the potential of Cannabis-Responsive biomarkers as a powerful tool in quantifying, at the metabolic level, the benefits of successful medical cannabis treatment in children with ASD. Study results also show the potential of Cannabis-Responsive biomarkers to provide insights...

Click to view original post